semaglutide .50 weight loss 11 MONTHS ON Semaglutide Weight Loss Injections in

Indications and Usage Wegovy (semaglutide) injection is indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight To reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients 12 years and older with obesity Adults with overweight in the presence of at least one weight-related comorbidity Wegovy (semaglutide) tablets are indicated in combination with a reduced calorie diet and increased physical activity to: Reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight Reduce excess body weight and maintain weight reduction long term in adults with obesity or with overweight in the presence of at least one weight-related comorbidity Limitations of Use: Concomitant use of Wegovy tablets or Wegovy injection with other semaglutide-containing products or with any GLP-1 receptor agonist is not recommended Reference Wegovy [package insert]

Reduces liver glucose, improves insulin sensitivity

Jun 2019;31(3):195-199

For some people, when they hear the word IGF-1, the first thing that comes to mind is performance-enhancing drugs

Compounded medications provide for customization of strengths and volumes, as determined necessary by the prescribing physician for the identified patient, that may not be available in commercial products

aging Res